E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/6/2005 in the Prospect News Biotech Daily.

Chiron kept by Thomas Weisel at peer perform

Chiron Corp. was maintained by Thomas Weisel Partners at a peer perform rating following news that the company had rejected a $40 per share takeover offer from Novartis AG. Thomas Weisel believes it will take an offer between $43 and $45 per share to get the acquisition done but that it's unlikely a bidding war will break out. Chiron shares Tuesday were up $0.72, or 1.68%, at $43.51 on volume of 2,602,311 shares versus the three-month running average of 1,578,500 shares.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.